The chemical class known as Cdc14a phosphatase Inhibitors consists of compounds that can modulate the activity of Cdc14a phosphatase, a critical enzyme in cell cycle regulation. These compounds, while not directly antagonistic to Cdc14a phosphatase, operate by influencing cellular pathways and processes in which Cdc14a phosphatase is a crucial participant. The indirect approach to modulating Cdc14a phosphatase reflects the enzyme's complex role within the network of cell cycle regulation. Cdc14a phosphatase is essential for the proper progression and regulation of various stages of the cell cycle, particularly during mitosis and cytokinesis, making it a key point of interest in cellular division studies and its associated dysregulations.
The primary mode of action of these compounds involves targeting crucial processes like cell cycle progression, DNA repair mechanisms, and mitotic processes. By impacting these pathways, the compounds can indirectly affect the functionality of Cdc14a phosphatase. For instance, compounds that disrupt the orderly progression of the cell cycle can significantly impact the role of Cdc14a phosphatase in regulating mitotic exit and cytokinesis. This might involve altering the dephosphorylation of substrates essential for transitioning between cell cycle phases. Moreover, compounds that induce DNA damage or modulate the DNA damage response can indirectly influence the function of Cdc14a phosphatase. Given its role in the DNA damage response, particularly concerning the stabilization and activity of DNA repair proteins, modifying these pathways can have implications for Cdc14a phosphatase's activity. This indirect modulation approach underscores the complexity of targeting a protein as crucial as Cdc14a phosphatase within the cell cycle. Developing and studying Cdc14a phosphatase modulating compounds is a significant part of current research, aimed at unraveling the detailed roles of Cdc14a phosphatase in cell cycle regulation and exploring methods to influence its activity in various cellular contexts. Research into the effects of these compounds on Cdc14a phosphatase provides valuable insights into cell cycle regulation, genomic integrity maintenance, and the ramifications of cell cycle dysregulation.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $315.00 | ||
Could possibly inhibit CDC14A phosphatase by disrupting CDK4/6, affecting the regulatory role of CDC14A in the cell cycle. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
Could possibly inhibit CDC14A phosphatase by affecting CDKs, impacting cell cycle transitions and CDC14A phosphatase's function in mitotic exit and cytokinesis. | ||||||
Olomoucine | 101622-51-9 | sc-3509 sc-3509A | 5 mg 25 mg | $72.00 $274.00 | 12 | |
Could possibly inhibit CDC14A phosphatase by influencing cell cycle regulation through CDK inhibition, potentially impacting CDC14Aphosphatase -mediated processes. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
Could possibly inhibit CDC14A by destabilizing microtubules, affecting mitotic spindle formation and CDC14A's role in centrosome duplication and separation. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $40.00 $73.00 $217.00 $242.00 $724.00 $1196.00 | 39 | |
Could possibly inhibit CDC14A by stabilizing microtubules, impacting cell division and CDC14A's function in mitotic exit and cytokinesis. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $108.00 | 28 | |
Could possibly inhibit CDC14A by disrupting ATM kinase, impacting the DNA damage response and CDC14A's involvement in this pathway. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
Could possibly inhibit CDC14A by modulating CHK1 kinase, affecting the DNA damage response and cell cycle checkpoints, potentially impacting CDC14A's function. | ||||||
UCN-01 | 112953-11-4 | sc-202376 | 500 µg | $246.00 | 10 | |
Could possibly inhibit CDC14A by affecting various cell cycle-related kinases, potentially influencing CDC14A-mediated cell cycle regulation. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $82.00 $300.00 $1082.00 | 30 | |
Could possibly inhibit CDC14A by inducing DNA replication stress through DNA polymerase disruption, potentially impacting CDC14A's role in the cell cycle. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
Could possibly inhibit CDC14A by inducing DNA damage through topoisomerase II disruption, potentially affecting CDC14A's involvement in DNA repair mechanisms. | ||||||